1. Screening Libraries
  2. JAK/STAT Compound Library

JAK/STAT Compound Library

Cat. No.: HY-L008
Library Contents: XLSX PDF

A unique collection of 98 bioactive compounds related to JAK/STAT signaling used for high throughput screening (HTS) and high content screening (HCS).

Size (Pre-dissolved DMSO or Solid) Price Stock
30 μL/well (10 mM solution) Get quote In-stock
50 μL/well (10 mM solution) Get quote In-stock
100 μL/well (10 mM solution) Get quote In-stock
250 μL/well (10 mM solution) Get quote In-stock

Please contact us at

[email protected]

Top Publications Citing Use of Products

MCE Screening Library Partners

  • Description

  • Product Details

  • Composition

  • Contents

  • Documentation

Description
& Advantages

•   A unique collection of 98 bioactive compounds related to JAK/STAT signaling used for high throughput screening (HTS) and high content screening (HCS).

•   Targets include JAK, STAT, EGFR, Pim, etc.

•   A useful tool for JAK/STAT-related drug discovery.

•   Bioactivity and safety confirmed by preclinical research and clinical trials. Some inhibitors have been approved by FDA.

•   Structurally diverse, medicinally active, and cell permeable.

•   More detailed compound information with structure, IC50, and brief introduction.

•   NMR and HPLC validated to ensure high purity and quality.

•   All compounds are in stock and continuously updated.

Product Details
Formulation:
A collection of 98 JAK/STAT related compounds supplied as pre-dissolved DMSO solutions or Solid
Container:
96 Well Format Sample Storage Tube With Screw Cap and Optional 2D Barcode
Storage:
-80°C
Shipping:
Blue ice
Composition

JAK/STAT Compound Library

Source: MedChem Express

Contents of JAK/STAT Compound Library

Plate layout: HY-L008-1

1 2 3 4 5 6 7 8 9 10 11 12
a Empty AG 18 Stattic Alantolactone Napabucasin SMI-16a Leflunomide Genistein Butein TCS-PIM-1-4a RG14620 Empty
b Empty Nifuroxazide STAT5-IN-1 AG-490 Cryptotanshinone JANEX-1 Ruxolitinib AG-1478 Tyrphostin AG 879 AG 555 Peficitinib Empty
c Empty PD158780 Pim1/AKK1-IN-1 AZD-1480 WP1066 Balsalazide PD153035 NSC 74859 TCS PIM-1 1 ZM39923 (hydrochloride) PD168393 Empty
d Empty Baricitinib SB1317 WHI-P154 AZD1208 CL-387785 AT9283 EAI045 BIBX 1382 Solcitinib Erlotinib Empty
e Empty AS1517499 Ruxolitinib (phosphate) SGI-1776 CYT387 TP-3654 Morusin CHZ868 GLPG0634 Icotinib (Hydrochloride) Erlotinib (Hydrochloride) Empty
f Empty BMS-911543 CUDC-101 AEE788 Cerdulatinib Gefitinib Oclacitinib (maleate) WHI-P97 Oleanolic Acid AZD3759 CX-6258 Empty
g Empty Scutellarin CEP-33779 HO-3867 Pelitinib Mubritinib Baricitinib (phosphate) CP-724714 Dacomitinib LY2784544 Sapitinib Empty
h Empty Irbinitinib AZ-5104 Afatinib Olmutinib Poziotinib WZ4002 AZD-9291 Tofacitinib (citrate) TG101209 TG-101348 Empty

Plate layout: HY-L008-2

1 2 3 4 5 6 7 8 9 10 11 12
a Empty CNX-2006 Homoharringtonine TAK-285 CO-1686 Neratinib Canertinib (dihydrochloride) NVP-BSK805 (dihydrochloride) BMS-599626 (Hydrochloride) Lapatinib AZD-9291 (mesylate) Empty
b Empty Avitinib (maleate) SH-4-54 CYT387 (sulfate salt) Ginsenoside Rh2 BP-1-102 CO-1686 (hydrobromide) Afatinib (dimaleate) Lapatinib (ditosylate) Empty Empty Empty
c Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty
d Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty
e Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty
f Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty
g Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty
h Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty
Documentation

Inquiry Online

Your information is safe with us. * Required Fields.

Product name

 

Salutation

Applicant name *

 

Email address *

Phone number

 

Organization name *

Country *

 

Requested quantity *

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
JAK/STAT Compound Library
Cat. No.:
HY-L008
Quantity:

Request SDF File

Please enter your email address. We will send your requested SDF file to you as soon as possible.